THW - Tekla World Healthcare Fund
NYSE
->
Financial Services
->
Asset Management
Boston,
United States
Type: Equity
THW price evolution
THW
| (in millions $) | 30 Oct 2023 | 1 May 2023 | 30 Oct 2022 | 1 May 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0 | $0 | $0 | $0 |
| Short term investments | ||||
| Net receivables | $2.62 | $2.96 | $3.09 | $5.68 |
| Inventory | ||||
| Total current assets | $2.95 | $3.33 | $3.34 | $5.78 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $569.74 | $607.18 | $582.93 | $679.5 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $2.4 | $7.11 | $7.31 | $4.96 |
| Long term debt | $120 | $120 | $120 | $120 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $122.62 | $127.56 | $128.59 | $127.41 |
| Shareholders' equity | ||||
| Retained earnings | -$56.72 | -$44.64 | -$63.93 | $14.5 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2023 | 30 Oct 2022 | 30 Oct 2021 | 30 Oct 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0 | $0 | $0 | $1.4 |
| Short term investments | ||||
| Net receivables | $2.62 | $3.09 | $2.76 | $2.5 |
| Inventory | ||||
| Total current assets | $2.95 | $3.34 | $2.81 | $3.9 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $569.74 | $582.93 | $714.18 | $548.1 |
| Current liabilities | ||||
| Accounts payable | $22.18 | |||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $2.4 | $7.31 | $27.83 | $0.8 |
| Long term debt | $120 | $120 | $120 | $120 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $122.62 | $128.59 | $148.5 | $121.6 |
| Shareholders' equity | ||||
| Retained earnings | -$56.72 | -$63.93 | $29.97 | -$50.5 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2023 | 1 May 2023 | 30 Oct 2022 | 1 May 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.96 | $6.81 | $5.68 | $6.43 |
| Cost of revenue | ||||
| Gross Profit | -$1.22 | $0.41 | $0.74 | $2.11 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $0.39 | $0.42 | $0.5 | $0.41 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$6.44 | $45.67 | -$73.73 | $8.94 |
| Net income | ||||
| Net income | -$8.05 | $45.67 | -$73.48 | $10.65 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2023 | 30 Oct 2022 | 30 Oct 2021 | 30 Oct 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12.78 | $12.11 | $11.49 | $12.12 |
| Cost of revenue | ||||
| Gross Profit | -$0.8 | $2.85 | $3.41 | $3.59 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $0.81 | $0.91 | $0.74 | $0.67 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | $39.23 | -$64.78 | $82.46 | $57.98 |
| Net income | ||||
| Net income | $37.62 | -$62.84 | $85.13 | $60.9 |
| Income (for common shares) | ||||
| (in millions $) | 1 May 2023 | 30 Oct 2022 | 1 May 2022 | 30 Oct 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | -$24.33 | -$48.5 | -$24.24 | -$44.82 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$20.39 | -$48.5 | -$24.24 | $54.01 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.01 | -$0.04 | -$0.03 | -$1.33 |
| (in millions $) | 30 Oct 2023 | 30 Oct 2022 | 30 Oct 2021 | 30 Oct 2020 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | -$48.79 | -$48.5 | -$44.82 | -$41.43 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$44.84 | -$48.5 | $54.01 | -$42.01 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0 | -$0.04 | -$1.33 | -$3.83 |
News
|
Tekla World Healthcare Fund's Dividend Analysis
GuruFocus.com via Yahoo Finance
18 Oct 2023
|
|
Unpacking Tekla World Healthcare Fund's Dividend Performance
GuruFocus.com via Yahoo Finance
19 Sep 2023
|
|
Needy Fund aids family with a critically injured child
Cape Cod Times via Yahoo News
30 Nov 2022
|
|
THW continues To Be A Safe Bet For Income Seeking Investors
Seeking Alpha
4 May 2022
|
|
Tekla World Healthcare Fund (NYSE:THW) Short Interest Up 89.9% in April
ETF DAILY NEWS
30 Apr 2022
|
|
Tekla Life Sciences: Buy For The Yield (NYSE:HQL)
Seeking Alpha
27 Apr 2022
|
|
Billionaire Investors Are Buying Healthcare Hand Over Fist
Seeking Alpha
21 Apr 2022
|
|
Tekla World Healthcare Fund (NYSE:THW) Short Interest Up 130.6% in March
ETF DAILY NEWS
16 Apr 2022
|
|
Tekla World Healthcare Fund (THW) To Go Ex-Dividend on April 20th
ETF DAILY NEWS
14 Apr 2022
|
|
4 'Double Discounted' CEFs Yielding Up To 9.1% | Investing.com
Investing.com
14 Apr 2022
|
Fundamentals
| Market cap | $490.90M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 38.11M |
| Revenue | $24.89M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$25.21M |
| Revenue Q/Q | 5.17% |
| Revenue Y/Y | 5.36% |
| P/E ratio | -19.47 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 19.73 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.00 |
| EPS | -$0.66 |
|---|---|
| ROA | -4.13% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.23 |
| Quick ratio | N/A |